Sponsors and Media | Australian Dementia Research Forum 2024

Turning the Tide on Dementia

OPPORTUNITY TO PARTNER WITH US

Our sponsors and exhibitors are an integral and essential component of our discipline. The ADRF2024 will be providing a unique opportunity for all those involved in the dementia network of prevention, treatment and care to come together to share knowledge, engage and connect. Your participation will enable maximum visibility for your organisation, its services and products.

To find out more about the packages available, please download the prospectus below or contact:

Alida Apostoloudas at alida.a@unimelb.edu.au for further information.

DOWNLOAD PROSPECTUS

DOWNLOAD TERMS AND CONDITIONS

THANK YOU TO OUR SPONSORS

Platinum Partner

The Australian Government Department of Health and Aged Care develops and delivers policies and programs on health, aged care and sport. We work with a wide range of stakeholders to ensure better health and wellbeing for all Australians. The department is responsible for administering aged care legislation and developing policy that supports high quality, safe and sustainable aged care.

We deliver a broad range of programs relating to aged care, including in-home aged care, as well as funding for residential aged care. We also support people to navigate and access aged care services through My Aged Care. We also fund dementia programs to support people living with dementia, their families and carers.

We are making changes to aged care that will improve aged care in Australia now and into the future. Many of the changes are in response to the recommendations of the Royal Commission into Aged Care Quality and Safety.  Our vision is to deliver the highest quality person-centred care for older people – where and when they need it.

To find out more and to have your say about the changes, visit the Aged Care Engagement Hub: AgedCareEngagement.health.gov.au.

You can contact us on: dementia@health.gov.au

Diamond Sponsor

Lilly is a medicine company making life better for people around the world. We've turned science into pioneering new discoveries for nearly 150 years, and today, our medicines support more than 51 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges; redefining diabetes care; treating obesity; advancing the fight against Alzheimer's disease; providing options for some of the most debilitating immune system disorders; and targeting the most difficult-to-treat cancers.

For over 35 years, Lilly has driven scientific progress in Alzheimer’s disease to improve diagnostics, treatments, and outcomes for patients. It’s our vision that, in 10 years, timely detection, accurate diagnosis, appropriate treatment and ultimately prevention, will be a reality for people with Alzheimer’s disease. With each step towards a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more visit Lilly.com.au or follow us on LinkedIn.

Gold Sponsor

Dementia Australia is the source of trusted information, education and services for the estimated more than 421,000 Australians living with dementia, and the more than 1.6 million people involved in their care. We advocate for positive change and support vital research. We are here to support people impacted by dementia, and to enable them to live as well as possible. No matter how you are impacted by dementia or who you are, we are here for you.
For support, please contact the National Dementia Helpline on 1800 100 500. An interpreter service is available. The National Dementia Helpline is funded by the Australian Government. People looking for information can also visit dementia.org.au

Silver Sponsor

Eisai are a global leading research-based pharmaceutical company working in the neurology and oncology therapeutic areas. Eisai’s corporate mission is to give first thought to patients and their families, and to increase the benefits health care provides.